Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Crescita Therapeutics Inc (CTX.TO)

Crescita Therapeutics Inc (CTX.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 19,011
  • Shares Outstanding, K 20,891
  • Annual Sales, $ 16,628 K
  • Annual Income, $ 2,396 K
  • 60-Month Beta 1.88
  • Price/Sales 0.81
  • Price/Cash Flow N/A
  • Price/Book 0.88
  • Price/Earnings ttm 3.50
  • Earnings Per Share ttm 0.27
  • Most Recent Earnings 0.00 on 09/30/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.85 +7.06%
on 10/17/19
1.05 -13.33%
on 10/29/19
+0.06 (+7.06%)
since 10/15/19
3-Month
0.75 +21.33%
on 08/21/19
1.05 -13.33%
on 10/29/19
+0.01 (+1.11%)
since 08/15/19
52-Week
0.39 +133.33%
on 12/31/18
1.23 -26.02%
on 07/16/19
+0.43 (+89.58%)
since 11/15/18

Most Recent Stories

More News
Crescita Reports 2019 Third Quarter Results

Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA1 of $0.9 Million

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
Crescita Reports 2019 Third Quarter Results

Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA 1  of $0.9 Million

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription...

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

LAVAL, QC , Nov. 5, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription...

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita"), a Canadian commercial dermatology company,...

CRRTF : 0.7000 (unch)
SNDL : 3.13 (-3.99%)
CTX.TO : 0.91 (-2.15%)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

CALGARY and LAVAL, QC, Oct. 28, 2019 /PRNewswire/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX and OTC US:...

SNDL : 3.13 (-3.99%)
CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

CALGARY and LAVAL, QC , Oct. 28,  2019 /PRNewswire/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC...

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
SNDL : 3.13 (-3.99%)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

NEW YORK, NY / ACCESSWIRE / September 5, 2019 / Crescita Therapeutics Inc. (TSX:CTX)(OTC Pink:CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities...

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

LAVAL, QC , Sept. 5, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities...

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare...

CRRTF : 0.7000 (unch)
CTX.TO : 0.91 (-2.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft.

See More Share

Key Turning Points

2nd Resistance Point 0.91
1st Resistance Point 0.91
Last Price 0.91
1st Support Level 0.91
2nd Support Level 0.91

See More

52-Week High 1.23
Fibonacci 61.8% 0.91
Last Price 0.91
Fibonacci 50% 0.81
Fibonacci 38.2% 0.71
52-Week Low 0.39

See More

Business Summary

Crescita Therapeutics Inc is a commercial dermatology company with a portfolio of non-prescription skin care products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. It owns multiple proprietary drug delivery platforms that support the development...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar